Logo image
Inflammation, Microenvironment, and the Immune System in Cancer Progression
Journal article   Peer reviewed

Inflammation, Microenvironment, and the Immune System in Cancer Progression

Andrew Keibel, Vinod Singh and Mahesh C. Sharma
Current pharmaceutical design, v 15(17), pp 1949-1955
01 Jun 2009
PMID: 19519435

Abstract

Life Sciences & Biomedicine Pharmacology & Pharmacy Science & Technology
Since Virchow first proposed in 1863 that tumors could originate from sites of chronic inflammation, it has been well established that chronic inflammation both contributes to cancer progression and predisposes tissue to various types of cancer. Experimental, clinical, and epidemiological studies have all demonstrated the strong association between chronic inflammation and cancer, and many studies have correlated the prolonged presence of the inflammatory milieu with an increased risk for developing cancer. Proinflammatory cytokines, chemokines and adhesion molecules, which regulate the sequential recruitment of leukocytes, are frequently observed in tumor microenvironment. These early desmoplastic changes could stimulate fibroblasts and endothelial cell division and produce components for tissue remodeling and neovascularization, ultimately promoting neoplastic processes. In this review article we overview the current understanding of the role of chronic inflammation in neoangiogenesis, tumor initiation, promotion, and progression.

Metrics

7 Record Views
184 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
International collaboration
Web of Science research areas
Pharmacology & Pharmacy
Logo image